Literature DB >> 21450557

Detection of Staphylococcus aureus nasal carriage in healthy young adults from a Hungarian University.

Krisztina Laub1, Szilvia Kardos, K Nagy, Orsolya Dobay.   

Abstract

Asymptomatic carriage of Staphylococcus aureus in healthy individuals has a high prevalence, especially in children and young adults. Nasal colonisation is a well-known risk factor for subsequent severe infection, or can be the source of transmission of this bacterium to other susceptible persons. In this study, we have surveyed the nasal carriage rate of students of the Semmelweis University, by screening 300 volunteers. We have determined the antibiotic sensitivity of the isolates by Etest, and their genetic relatedness by pulsed-fieled gel electrophoresis. The nasal carriage rate of S. aureus was found to be 29.3%, and that of MRSA only 0.67% (2/300). The isolates were generally sensitive to antibiotics, except for macrolides. We could observe a noticeably great genetic diversity, even among strains deriving from students of the same university group.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21450557     DOI: 10.1556/AMicr.58.2011.1.8

Source DB:  PubMed          Journal:  Acta Microbiol Immunol Hung        ISSN: 1217-8950            Impact factor:   2.048


  3 in total

1.  Low nasal carriage of drug-resistant bacteria among medical students in Vienna.

Authors:  Guido A Gualdoni; Tilman Lingscheid; Selma Tobudic; Heinz Burgmann
Journal:  GMS Krankenhhyg Interdiszip       Date:  2012-04-04

2.  Prevalence of methicillin-resistant Staphylococcus aureus nasal colonization among medical students in Jeddah, Saudi Arabia.

Authors:  Shadi A Zakai
Journal:  Saudi Med J       Date:  2015-07       Impact factor: 1.484

3.  Whole genome sequencing of coagulase positive staphylococci from a dog-and-owner screening survey.

Authors:  Judit Sahin-Tóth; Eszter Kovács; Adrienn Tóthpál; János Juhász; Barbara Forró; Krisztián Bányai; Kata Havril; Andrea Horváth; Ágoston Ghidán; Orsolya Dobay
Journal:  PLoS One       Date:  2021-01-11       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.